Skip to main content
STRIDES PHARMA SCIENCE LIMITED logo

STRIDES PHARMA SCIENCE LIMITED — Investor Relations & Filings

Ticker · STAR ISIN · INE939A01011 LEI · 335800WHFYXUCHR9DD10 BSE.NS Manufacturing
Open in API
Filings indexed 1,200 across all filing types
Latest filing 2024-05-16 Regulatory Filings
Country IN India
Listing BSE.NS STAR

About STRIDES PHARMA SCIENCE LIMITED

https://www.strides.com

Strides Pharma Science Limited is a global pharmaceutical organization focused on the development and manufacture of IP-led niche finished dosage formulations. The company’s product portfolio encompasses a wide range of therapeutic areas, specializing in complex oral solids, softgel capsules, topicals, and liquids. It maintains a significant presence in highly regulated markets, including the United States, Europe, and Australia, while also serving institutional and emerging markets. The company operates multiple manufacturing facilities globally, many of which are approved by major international regulatory agencies such as the USFDA. Strides emphasizes research and development to drive innovation in specialized delivery systems and difficult-to-manufacture products, positioning itself as a key player in the global generic pharmaceutical landscape.

Recent filings

Filing Released Lang Actions
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2024-05-16 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a notification about an upcoming earnings call scheduled for May 22, 2024, to discuss the audited financial results for the quarter and year ended March 31, 2024. It includes dial-in details and mentions that the audio and transcript will be uploaded later on the company's website. The document does not contain actual financial data or the transcript itself, but rather serves as an announcement for the earnings call event. According to the classification rules, such notifications are classified as Call Transcript (CT) only if they contain the full transcript. Since this is only an announcement of the call, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and notification. The document length is short (2694 characters), supporting that it is not the full transcript or report.
2024-05-16 English
Board Meeting — STRIDES PHARMA SCIENCE LIMITED has informed the Exchange about Board Meeting to be held on 22-May-2024 to consider and approve the Yearly Audited Financial results of the Company for…
Regulatory Filings
2024-05-14 English
Board Meeting — Financial Results/Dividend
Board/Management Information Classification · 95% confidence The document is a short announcement addressed to stock exchanges about an upcoming Board Meeting scheduled for May 22, 2024. It mentions the agenda items including approval of audited financial results and dividend consideration. The document is brief (1428 characters) and serves as a notification rather than containing any financial data or detailed report. It specifically relates to a Board Meeting announcement under SEBI Listing Regulations. Therefore, it fits the category of Board/Management Information (MANG) rather than an actual financial report or earnings release.
2024-05-14 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release announcing the USFDA approval of a pharmaceutical product by Strides Pharma Science Limited. It is addressed to stock exchanges and includes details about the product, company background, and contact information. The document is short (3982 characters) and does not contain financial statements, detailed financial analysis, or regulatory filings. It is an announcement of a corporate event (product approval) rather than a financial report or regulatory filing. Therefore, it does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. The best fitting category is Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2024-05-10 English
Loss of Share Certificates
Regulatory Filings
2024-05-06 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.